On 4 December, GSK's CEO
Andrew Witty
met with President Carter
to celebrate
the
10th anniversary
of the successful
collaboration
against lymphatic filariasis.
GSK has suppported The Carter Center's
work
for 10 years with remarkable progress
being made to rid the world of this debilitating
disease.
09 January 2009
GSK and Xenoport resubmit new drug application for Solzira™ in restless legs syndrome
07 January 2009
GlaxoSmithKline successfully completes tender offer for shares of Genelabs Technologies, Inc.
23 December 2008
Cytokinetics retains development and commercialization rights to ispinesib and SB-743921
![]()